Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety

Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.
Latest website image capture
Clouds background image

Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a Locations section detailing study sites across multiple states, countries, and cities, broadening enrollment sites.
    Difference
    3%
    Check dated 2025-12-23T22:32:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Publications section now states that PubMed-sourced publications are automatically populated and may not all relate to the study, and the revision version updated to v3.3.2 (replacing v3.2.0).
    Difference
    0.4%
    Check dated 2025-11-25T14:42:31.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Deleted the boilerplate government funding/operating status notice from the page. Core study details, eligibility criteria, and locations remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-18T07:26:32.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The screenshots show the same Study Details page with only minor visual/layout differences; no core content such as study design, outcomes, or eligibility criteria appears to have changed.
    Difference
    0.1%
    Check dated 2025-10-27T21:08:24.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T08:57:11.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.3%
    Check dated 2025-09-29T07:32:26.000Z thumbnail image

Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety

Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.